Johns Hopkins University
This study will screen people for biomarkers of Human Papillomavirus (HPV) to form a cohort of people who may be at increased risk of HPV-oropharyngeal cancer (HPV-OPC). The investigators will follow these individuals prospectively to evaluate risk for OPC.
This study will assess HPV16 biomarkers, including serum HPV16 E6 antibodies, plasma and oral HPV16 DNA, and ultrasound, to understand the feasibility and utility of HPV16 biomarker screening to identify those at increased risk of HPV-OPC. This study will screen approximately 2500 people. The focus of the study is to determine whether sequential testing for oral and plasma HPV16 DNA, among those with HPV16 E6 antibodies, improves identification of persistent HPV16 biomarkers indicative of preclinical HPV-OPC and HPV-OPC compared to standalone testing with HPV16 E6 antibodies among people with…
Inclusion Criteria: * Part I: Participants in Screening To be eligible to participate in Part I of this study, an individual must meet the following criteria: Community and Internet Screen eligibility: * Male, 40-69 years old * Willing to self-collect or come in person to collect screening biospecimens * Willing to be contacted to arrange follow-up visits, if determined to be eligible for follow-up * Ability to understand and the willingness to sign a written informed consent document Biorepository Screen eligibility: * Male, 40-69 years old * Active participant within MWCCS * Willing to…
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.